http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10865754

Outgoing Links

Predicate Object
contentType Journal Article|Review
issn 2072-6694
issueIdentifier 5
pageRange 1295-
publicationName Cancers
startingPage 1295
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cb2895ec94b507d2e7bae1112ac11389
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0c6264d8a51e6b3fdde25cc993172483
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d20957ff49ef475fe825d94c7e892677
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f00c0b655bb459f1373419c4bd7634f9
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc11c6d32e5090fad207ddeb3bcfeb53
bibliographicCitation Sato-Dahlman M, LaRocca CJ, Yanagiba C, Yamamoto M. Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination. Cancers (Basel). 2020 May 21;12(5). PMID: 32455560; PMCID: PMC7281656.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9808-1405
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8901b4c4389cb1aef47b0aba468dc178
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a5b5efdf87c4c20b564e584abcb4c92
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2019-5557
date 2020-05-21^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/32455560
https://doi.org/10.3390/cancers12051295
https://pubmed.ncbi.nlm.nih.gov/PMC7281656
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37563
https://portal.issn.org/resource/ISSN/2072-6694
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 31 of 31.